NIDA-41020 is primarily utilized in research settings to study the endocannabinoid system and its interactions with cannabinoid receptors. It serves as a valuable tool for understanding the pharmacological effects of cannabinoids, particularly in the context of pain management, neuroprotection, and inflammation. Researchers employ this compound to explore its potential therapeutic applications, such as in the development of treatments for neurological disorders, chronic pain, and conditions influenced by the endocannabinoid system. Additionally, it aids in the investigation of receptor binding mechanisms and the development of novel cannabinoid-based drugs.